This article is more than 5 years old. Information may no longer be current.

VIDEO: Thyroid ‘year in review’ covers clinical studies with impact

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO— In this video exclusive, Naifa Lamki Busaidy, MD, FACP, FACE, associate professor in the department of endocrine neoplasia and hormonal disorders at The University of Texas MD Anderson Cancer Center in Houston, discusses recent peer-reviewed research that has had an impact on medical thyroidology — from hypothyroidism to thyroid cancer.

References in order of presentation are below:

Hypothyroidism

• Dhillon-Smith RK, et al. N Eng J Med. 2019;doi:10.1056/NEJMoa1812537.
• Guldvog I, et al. Ann Intern Med. 2019;doi: 10.7326/M18-0284.

Hyperthyroidism

• Azizi F, et al. Thyroid. 2019;doi: 10.1089/thy.2019.0180.

Morbidities from other therapies

• Kitahara CM, et al. JAMA Intern Med. 2019;doi:10.1001/jamainternmed.2019.0981.
• Okosieme OE, et al. Lancet Diabetes Endocrinol. 2019;doi: 10.1016/S2213-8587(19)30059-2.
• Iyer PC, et al. Thyroid. 2018;doi: 10.1089/thy.2018.0116.

Thyroid cancer

• Oh HS, et al. Thyroid. 2019;doi:10.1089/thy.2018.0609
• Papaleontiou M, et al. Thyroid. 2019;doi:10.1089/thy.2019.0163.
• Wallner LP, et al. J Clin Oncol. 2019;doi:10.1200/JCO.18.02228.

Disclosure: Busaidy reports she has received consultant fees from Eisai and Loxo Oncology and research funding from Novartis.